Navigation Links
Anadys Pharmaceuticals to Present at the Cowen & Company Healthcare Conference
Date:3/1/2011

statements include, but are not limited to, references to Anadys' strategy, development programs, and ability to develop novel medicines for the treatment of hepatitis C.  Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause Anadys' actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements.  For example, the results of preclinical and early clinical studies may not be predictive of future results, and Anadys cannot provide any assurances that ANA598 or ANA773 will not have unforeseen safety issues, will have favorable results in ongoing or future clinical trials or will receive regulatory approval.  Risk factors that may cause actual results to differ are more fully discussed in Anadys' SEC filings, including Anadys' Form 10-Q for the quarter ended September 30, 2010.  All forward-looking statements are qualified in their entirety by this cautionary statement.  Anadys is providing this information as of this date and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise.


'/>"/>
SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
2. Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection
3. Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside Inhibitor of the HCV Polymerase, at the 21st International Conference on Antiviral Research
4. Anadys Pharmaceuticals Initiates Phase I Clinical Trial of ANA598
5. Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV
6. Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients
7. Anadys Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference
8. Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers
9. Anadys Pharmaceuticals Commences Dosing in Phase II Study of ANA598
10. Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Anadys Pharmaceuticals to Present at the Oppenheimer Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... , March 6, 2015  Pomerantz LLP is ... Inc. ("Conatus" or the "Company") (NASDAQ: CNAT ... S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ... and certain of its officers and/or directors have violated ... of 1934.  On March 5, 2015, ...
(Date:3/6/2015)... , March 6, 2015   Prime Therapeutics ... more than 26 million members, today released the following ... (FDA) approval of the first biosimilar to enter the ... Drug Administration (FDA) approval of Sandoz,s Zarxio® to treat ... patients, is a major milestone in our country,s journey ...
(Date:3/6/2015)... DALLAS , March 6, 2015  Ascendant Solutions, ... the "Company") today announced its results for the fourth ... reported consolidated net income of $105,000, or less than ... quarter ended December 31, 2014.  This compares with net ... of $6,551,000 for the fourth quarter of 2013. The ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Conatus Pharmaceuticals Inc. - CNAT 2Prime Therapeutics welcomes FDA's approval of first biosimilar in U.S., but says more clarity is needed 2Prime Therapeutics welcomes FDA's approval of first biosimilar in U.S., but says more clarity is needed 3Ascendant Solutions, Inc. Reports Fourth Quarter and Year End 2014 Earnings 2Ascendant Solutions, Inc. Reports Fourth Quarter and Year End 2014 Earnings 3Ascendant Solutions, Inc. Reports Fourth Quarter and Year End 2014 Earnings 4Ascendant Solutions, Inc. Reports Fourth Quarter and Year End 2014 Earnings 5
... AUSTIN, Texas, Dec. 12, 2011  There is new hope for ... as "foot drop" due to cerebral palsy (CP).  At ... Cerebral Palsy Developmental Medicine on Saturday, October 15, researchers ... study that shows the WalkAide System successfully improves mobility ...
... Dec. 12, 2011 Reportlinker.com announces that ... in its catalogue: Global ... http://www.reportlinker.com/p0703211/Global-Hospital-Information-Systems-HIS-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=e-Healthc This ... Information Systems (HIS) in US$ Millions by ...
Cached Medicine Technology:NIH Study Shows WalkAide Device by Hanger Orthopedic Group Significantly Improves Walking Ability In Children With Cerebral Palsy 2NIH Study Shows WalkAide Device by Hanger Orthopedic Group Significantly Improves Walking Ability In Children With Cerebral Palsy 3NIH Study Shows WalkAide Device by Hanger Orthopedic Group Significantly Improves Walking Ability In Children With Cerebral Palsy 4Global Hospital Information Systems (HIS) Industry 2Global Hospital Information Systems (HIS) Industry 3Global Hospital Information Systems (HIS) Industry 4Global Hospital Information Systems (HIS) Industry 5Global Hospital Information Systems (HIS) Industry 6Global Hospital Information Systems (HIS) Industry 7Global Hospital Information Systems (HIS) Industry 8Global Hospital Information Systems (HIS) Industry 9Global Hospital Information Systems (HIS) Industry 10Global Hospital Information Systems (HIS) Industry 11Global Hospital Information Systems (HIS) Industry 12Global Hospital Information Systems (HIS) Industry 13Global Hospital Information Systems (HIS) Industry 14Global Hospital Information Systems (HIS) Industry 15Global Hospital Information Systems (HIS) Industry 16Global Hospital Information Systems (HIS) Industry 17Global Hospital Information Systems (HIS) Industry 18Global Hospital Information Systems (HIS) Industry 19Global Hospital Information Systems (HIS) Industry 20Global Hospital Information Systems (HIS) Industry 21Global Hospital Information Systems (HIS) Industry 22
(Date:3/6/2015)... Santa Clara, CA (PRWEB) March 06, 2015 ... Bryan tickets at Levi's® Stadium in Santa Clara, California. ... it has already hosted a plethora of exciting events. , ... Bryan will bring his popular summer tour to the west ... of the art facility will take place on August 29 ...
(Date:3/6/2015)... Jose, California (PRWEB) March 06, 2015 ... also known as the pharmacokinetics of a drug refers ... a pharmaceutical compound inside an organism. When toxicity studies ... ADME-Tox or ADMET or ADME/Tox. Increasing focus on lowering ... adoption of ADME-toxicology testing worldwide. The traditional drug development ...
(Date:3/6/2015)... 06, 2015 Parents need to start ... of substance use disorders. School programs like DARE, or ... successful. NOPE, or Narcotics Overdose Prevention and Education has ... Healthline News on Feb. 27th. As teens ... opiate drugs, drug prevention proponents are lobbying Florida to ...
(Date:3/6/2015)... California (PRWEB) March 06, 2015 Johnson ... million jury verdict on March 5, 2015 in Superior ... According to court documents, a jury of 12 awarded ... suffered from being implanted with an Ethicon TVT Abbrevo ... nine men and three women also awarded $5 million ...
(Date:3/6/2015)... DC (PRWEB) March 06, 2015 Magellan ... nation’s only comprehensive source for key trends and statistics ... spend, medical injectables. Executives from Magellan Rx Management will ... Trend Report: Discover Your Hidden Specialty Drug Spend,” a ... Information Services, Inc. , Specialty drug spend makes up ...
Breaking Medicine News(10 mins):Health News:Cheap Luke Bryan Tickets at Levi's® Stadium in Santa Clara, CA: Ticket Down Slashes Ticket Prices on Luke Bryan Concert Tickets in Santa Clara at the New Levi's® Stadium 2Health News:Cheap Luke Bryan Tickets at Levi's® Stadium in Santa Clara, CA: Ticket Down Slashes Ticket Prices on Luke Bryan Concert Tickets in Santa Clara at the New Levi's® Stadium 3Health News:Growing Need to Reduce Drug Development Costs Drives the Global ADME-Toxicology Testing Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Growing Need to Reduce Drug Development Costs Drives the Global ADME-Toxicology Testing Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:A Harbor Village Detox Clinical Psychologist Encourages School Programs like NOPE to Positively Impact Awareness of Substance Use Disorders 2Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 2Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 3Health News:Atlantic Information Services, Magellan Rx Management Partner on Complimentary Webinar Outlining Key Findings of New Medical Pharmacy Trend Report 2
... - 20% U.S. Sequential Quarterly Sales Increase - ... - FY08 Revenue Projection Raised - ... - Conference Call to be Held at 10:00 a.m. Central Time Today -, ... for the second quarter,of fiscal 2008 ended September 30, 2007, up 73% from $1.8 million ...
... Adults Reap Significant Benefits in Less than a ... American Council on Exercise,(ACE), your premier certification, education ... study that examined functional,fitness programming for older adults; ... world benefits relatively quickly. With the goal of ...
... parameters published in the November 1 issue of the ... and treatment of circadian rhythm sleep disorders (CRSDs). ... behavior, patient outcomes and possibly health care costs. , ... practice parameters, commissioned content experts in CRSDs to review ...
... BERKELEY, Calif., Nov. 1 Dynavax Technologies,Corporation (Nasdaq: ... the third,quarter and nine months ended September 30, ... of today,s arrangement with Merck. As of ... securities and investments held by Symphony Dynamo, Inc. ...
... LONDON, Nov. 1 Chiltern, a leading global clinical,research organization ... at,the Annual Partnerships in Clinical Trials Conference; which will be ... Exhibit and,Congress Center. Chiltern will sponsor "welcome coffee breaks" from ... 9:00 am on Nov. 7th. Chiltern will,also be present at ...
... time when the U.S. spends more than double what other ... Commonwealth Fund seven-nation survey finds that U.S. patients are more ... because of costs, and to say that the health care ... with Canadians, are also the least likely to be able ...
Cached Medicine News:Health News:Uroplasty, Inc. Reports Record Sales For Second Fiscal Quarter 2Health News:Uroplasty, Inc. Reports Record Sales For Second Fiscal Quarter 3Health News:Uroplasty, Inc. Reports Record Sales For Second Fiscal Quarter 4Health News:Uroplasty, Inc. Reports Record Sales For Second Fiscal Quarter 5Health News:Uroplasty, Inc. Reports Record Sales For Second Fiscal Quarter 6Health News:Uroplasty, Inc. Reports Record Sales For Second Fiscal Quarter 7Health News:Uroplasty, Inc. Reports Record Sales For Second Fiscal Quarter 8Health News:Uroplasty, Inc. Reports Record Sales For Second Fiscal Quarter 9Health News:Uroplasty, Inc. Reports Record Sales For Second Fiscal Quarter 10Health News:Uroplasty, Inc. Reports Record Sales For Second Fiscal Quarter 11Health News:Exclusive American Council on Exercise (ACE) Research Study Proves Functional Fitness Really Works 2Health News:Practice parameters discuss the evaluation, treatment of circadian rhythm sleep disorders 2Health News:Practice parameters discuss the evaluation, treatment of circadian rhythm sleep disorders 3Health News:Dynavax Announces Third Quarter 2007 Financial Results and Updates 2007 Financial Outlook 2Health News:Dynavax Announces Third Quarter 2007 Financial Results and Updates 2007 Financial Outlook 3Health News:Dynavax Announces Third Quarter 2007 Financial Results and Updates 2007 Financial Outlook 4Health News:Dynavax Announces Third Quarter 2007 Financial Results and Updates 2007 Financial Outlook 5Health News:Dynavax Announces Third Quarter 2007 Financial Results and Updates 2007 Financial Outlook 6Health News:Dynavax Announces Third Quarter 2007 Financial Results and Updates 2007 Financial Outlook 7Health News:Dynavax Announces Third Quarter 2007 Financial Results and Updates 2007 Financial Outlook 8Health News:Dynavax Announces Third Quarter 2007 Financial Results and Updates 2007 Financial Outlook 9Health News:Chiltern to Participate at the Partnerships in Clinical Trials Conference in Amsterdam 2Health News:US adults most likely to report medical errors and skip needed care due to costs 2Health News:US adults most likely to report medical errors and skip needed care due to costs 3Health News:US adults most likely to report medical errors and skip needed care due to costs 4
Inquire...
Hydrophobic PE filter without self-sealing additives, permits sample recovery after accidental over-pipetting. All filters are sterile (to USP, DAB, Ph.Eur. standards) and PCR clean (free from human ...
Hydrophobic PE filter without self-sealing additives, permits sample recovery after accidental over-pipetting. All filters are sterile (to USP, DAB, Ph.Eur. standards) and PCR clean (free from human ...
... Aerosol barrier tips eliminate false signals ... designed and tested, Promega Barrier Tips ... with amplified nucleic acids (PCR(a)), radioactive ... forensic and serological specimens. , ,Promega ...
Medicine Products: